Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 44%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Hldgs is a dependable and reliable healthcare company that has a positive outlook due to its solid performance, strong cash flow, and focus on compliance and technology. Aveanna Healthcare's position in the Medicaid market and its emphasis on relationships and infrastructure make it a preferred provider, leading to increased stock price and growth expectations. However, potential risks regarding government reimbursement and M&A execution should be taken into consideration.

Bears say

Aveanna Healthcare Hldgs is facing significant sustainability issues due to the diverse and decentralized nature of its large workforce, as well as its susceptibility to fraud and abuse in the home healthcare industry. While the recent acquisition of Family First Homecare may provide a short-term boost to revenue and EBITDA, there are potential risks and uncertainties surrounding the integration and assimilation of the new operations. Additionally, while Aveanna's focus on value-based care models may align with sustainability considerations, it remains to be seen if this will translate into long-term financial success and sustainable growth for the company.

AVAH has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 44% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 9 analysts, AVAH has a Buy consensus rating as of Sep 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.06, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.06, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.